Published in Virchows Arch on April 12, 2006
Multifocal multi-site Warthin tumour. Eur Arch Otorhinolaryngol (2008) 1.15
Urothelial carcinoma with oncocytic features: an extremely rare case presenting a diagnostic challenge in urine cytology. Int J Clin Exp Pathol (2015) 0.75
A role for mitochondrial enzymes in inherited neoplasia and beyond. Nat Rev Cancer (2003) 2.26
Tissue that has lost its track: Warthin's tumour. Virchows Arch (2005) 1.68
Type and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients' age but not with tumour aggressiveness. Virchows Arch (2005) 1.62
Mitochondrial DNA somatic mutations (point mutations and large deletions) and mitochondrial DNA variants in human thyroid pathology: a study with emphasis on Hürthle cell tumors. Am J Pathol (2002) 1.61
Somatic and germline mutation in GRIM-19, a dual function gene involved in mitochondrial metabolism and cell death, is linked to mitochondrion-rich (Hurthle cell) tumours of the thyroid. Br J Cancer (2005) 1.39
Hürthle cell tumours of the thyroid. A review with emphasis on mitochondrial abnormalities with clinical relevance. Virchows Arch (2000) 1.09
Hürthle (oncocytic) cell tumors of thyroid: etiopathogenesis, diagnosis and clinical significance. Int J Surg Pathol (2005) 1.00
Mitochondrial DNA mutations in the parotid gland of cigarette smokers and non-smokers. Mutat Res (2002) 0.86
Oncocytic carcinoma arising in Warthin tumour. Virchows Arch (2004) 0.78
Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. J Natl Cancer Inst (2002) 4.43
BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC. Oncogene (2003) 3.34
Frequency of TERT promoter mutations in human cancers. Nat Commun (2013) 3.13
A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. Gastroenterology (2003) 2.39
BRAF mutations are associated with some histological types of papillary thyroid carcinoma. J Pathol (2004) 2.21
The new molecular markers DDIT3, STT3A, ARG2 and FAM129A are not useful in diagnosing thyroid follicular tumors. Mod Pathol (2011) 2.08
The diversity present in 5140 human mitochondrial genomes. Am J Hum Genet (2009) 1.90
TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas. J Clin Endocrinol Metab (2014) 1.71
Type and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients' age but not with tumour aggressiveness. Virchows Arch (2005) 1.62
Mitochondrial DNA somatic mutations (point mutations and large deletions) and mitochondrial DNA variants in human thyroid pathology: a study with emphasis on Hürthle cell tumors. Am J Pathol (2002) 1.61
Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening. J Pathol (2004) 1.59
BRAF mutations are not a major event in post-Chernobyl childhood thyroid carcinomas. J Clin Endocrinol Metab (2004) 1.52
How to Treat a Signal? Current Basis for RET-Genotype-Oriented Choice of Kinase Inhibitors for the Treatment of Medullary Thyroid Cancer. J Thyroid Res (2011) 1.46
Carcinoma of the thyroid with ewing family tumor elements and favorable prognosis: report of a second case. Int J Surg Pathol (2013) 1.46
Molecular and genotypic characterization of human thyroid follicular cell carcinoma-derived cell lines. Thyroid (2007) 1.41
Diffuse (or multinodular) follicular variant of papillary thyroid carcinoma: a clinicopathologic and immunohistochemical analysis of ten cases of an aggressive form of differentiated thyroid carcinoma. Virchows Arch (2001) 1.30
STAT3 negatively regulates thyroid tumorigenesis. Proc Natl Acad Sci U S A (2012) 1.23
Genetic alterations in poorly differentiated and undifferentiated thyroid carcinomas. Curr Genomics (2011) 1.18
Helicobacter pylori infection induces genetic instability of nuclear and mitochondrial DNA in gastric cells. Clin Cancer Res (2009) 1.14
Oncocytic lesions of the thyroid, kidney, salivary glands, adrenal cortex, and parathyroid glands. Int J Surg Pathol (2014) 1.10
Telomerase promoter mutations in cancer: an emerging molecular biomarker? Virchows Arch (2014) 1.09
mTOR pathway overactivation in BRAF mutated papillary thyroid carcinoma. J Clin Endocrinol Metab (2012) 1.08
A new BRAF gene mutation detected in a case of a solid variant of papillary thyroid carcinoma. Hum Pathol (2005) 1.04
Telomerase expression and proliferative activity suggest a stem cell role for thyroid solid cell nests. Mod Pathol (2004) 1.01
High frequency of germline succinate dehydrogenase mutations in sporadic cervical paragangliomas in northern Spain: mitochondrial succinate dehydrogenase structure-function relationships and clinical-pathological correlations. J Clin Endocrinol Metab (2007) 1.01
Intragenic mutations in thyroid cancer. Endocrinol Metab Clin North Am (2008) 1.00
Hürthle (oncocytic) cell tumors of thyroid: etiopathogenesis, diagnosis and clinical significance. Int J Surg Pathol (2005) 1.00
p63 expression in solid cell nests of the thyroid: further evidence for a stem cell origin. Mod Pathol (2003) 0.99
Mucins as key molecules for the classification of intestinal metaplasia of the stomach. Virchows Arch (2001) 0.98
BRAF mutations typical of papillary thyroid carcinoma are more frequently detected in undifferentiated than in insular and insular-like poorly differentiated carcinomas. Virchows Arch (2004) 0.95
Prognostic biomarkers in thyroid cancer. Virchows Arch (2014) 0.95
Patterns of beta-catenin expression in gastric carcinoma: clinicopathological relevance and mutation analysis. Int J Surg Pathol (2003) 0.93
The biology and the genetics of Hurthle cell tumors of the thyroid. Endocr Relat Cancer (2012) 0.92
Molecular genetics of papillary thyroid carcinoma: great expectations. Arq Bras Endocrinol Metabol (2007) 0.92
Cribriform-morular variant of papillary thyroid carcinoma: molecular characterization of a case with neuroendocrine differentiation and aggressive behavior. Am J Clin Pathol (2009) 0.91
B-RAF mutations in the etiopathogenesis, diagnosis, and prognosis of thyroid carcinomas. Hum Pathol (2006) 0.91
A follicular variant of papillary thyroid carcinoma in struma ovarii. Case report with unique molecular alterations. Histopathology (2009) 0.91
Germline succinate dehydrogenase subunit D mutation segregating with familial non-RET C cell hyperplasia. J Clin Endocrinol Metab (2003) 0.90
Molecular pathology of well-differentiated thyroid carcinomas. Virchows Arch (2005) 0.90
BRAF mutation in solid cell nest hyperplasia associated with papillary thyroid carcinoma. A precursor lesion? Hum Pathol (2009) 0.89
Involvement of p53 in cell death following cell cycle arrest and mitotic catastrophe induced by rotenone. Biochim Biophys Acta (2011) 0.89
Survey of 548 oncogenic fusion transcripts in thyroid tumors supports the importance of the already established thyroid fusions genes. Genes Chromosomes Cancer (2012) 0.88
A novel germline SDHB mutation in a gastrointestinal stromal tumor patient without bona fide features of the Carney-Stratakis dyad. Fam Cancer (2012) 0.87
Mitochondria dynamism: of shape, transport and cell migration. Cell Mol Life Sci (2014) 0.87
A polymorphism in the promoter region of the selenoprotein S gene (SEPS1) contributes to Hashimoto's thyroiditis susceptibility. J Clin Endocrinol Metab (2014) 0.86
Proliferation and survival molecules implicated in the inhibition of BRAF pathway in thyroid cancer cells harbouring different genetic mutations. BMC Cancer (2009) 0.86
Papillary thyroid microcarcinoma: how to diagnose and manage this epidemic? Int J Surg Pathol (2014) 0.86
Adenomas and follicular carcinomas of the thyroid display two major patterns of chromosomal changes. J Pathol (2005) 0.85
Cancer: Small papillary thyroid cancers--is BRAF of prognostic value? Nat Rev Endocrinol (2011) 0.85
RET/PTC rearrangement is prevalent in follicular Hürthle cell carcinomas. Histopathology (2012) 0.85
Stimulated thyroglobulin at recombinant human TSH-aided ablation predicts disease-free status one year later. J Clin Endocrinol Metab (2013) 0.84
A stem cell role for thyroid solid cell nests. Hum Pathol (2005) 0.84
The p75 neurotrophin receptor is widely expressed in conventional papillary thyroid carcinoma. Hum Pathol (2006) 0.83
Small-cell (basaloid) thyroid carcinoma: a neoplasm with a solid cell nest histogenesis? Int J Surg Pathol (2011) 0.83
Human papillomaviruses in intraepithelial neoplasia and squamous cell carcinoma of the conjunctiva: a study from Mozambique. Eur J Cancer Prev (2013) 0.83
Follicular, papillary, and "hybrid" carcinomas of the thyroid. Endocr Pathol (2002) 0.83
GRIM-19 in Health and Disease. Adv Anat Pathol (2008) 0.82
Mitochondria and cancer. Virchows Arch (2009) 0.81
An assessment of the clonality of the components of canine mixed mammary tumours by mitochondrial DNA analysis. Vet J (2008) 0.81
Acquisition of BRAF gene mutations is not a requirement for nodal metastasis of papillary thyroid carcinoma. Clin Endocrinol (Oxf) (2008) 0.81
Absence of the BRAF and the GRIM-19 mutations in oncocytic (Hürthle cell) solid cell nests of the thyroid. Am J Clin Pathol (2012) 0.81
The preeminence of growth pattern and invasiveness and the limited influence of BRAF and RAS mutations in the occurrence of papillary thyroid carcinoma lymph node metastases. Virchows Arch (2011) 0.81
A subset of the follicular variant of papillary thyroid carcinoma harbors the PAX8-PPARgamma translocation. Int J Surg Pathol (2005) 0.80
GRIM-19 function in cancer development. Mitochondrion (2011) 0.80
AZD1480 blocks growth and tumorigenesis of RET- activated thyroid cancer cell lines. PLoS One (2012) 0.80
Head and neck lesions in a cohort irradiated in childhood for tinea capitis treatment. Lancet Infect Dis (2011) 0.80
Molecular alterations and expression of succinate dehydrogenase complex in wild-type KIT/PDGFRA/BRAF gastrointestinal stromal tumors. Eur J Hum Genet (2012) 0.80
CDX2 Expression in Some Variants of Papillary Thyroid Carcinoma. Am J Clin Pathol (2012) 0.79
Expression of mucins (MUC1, MUC2, MUC5AC, and MUC6) and type 1 Lewis antigens in cases with and without Helicobacter pylori colonization in metaplastic glands of the human stomach. J Pathol (2002) 0.79
Tumor-in-tumor of the thyroid with basaloid differentiation: a lesion with a solid cell nest neoplastic component? Int J Surg Pathol (2011) 0.79
Mitochondrial D-Loop instability in thyroid tumours is not a marker of malignancy. Mitochondrion (2005) 0.78
Small cell tumors of the thyroid gland: a review. Int J Surg Pathol (2013) 0.78
Cribriform-morular variant of papillary thyroid carcinoma displaying poorly differentiated features. Int J Surg Pathol (2013) 0.78
Diagnostic criteria in well-differentiated thyroid carcinomas. Endocr Pathol (2006) 0.78
Reply to: Low prevalence of BRAF mutations in radiation-induced thyroid tumors in contrast to sporadic papillary carcinomas. Cancer Lett (2005) 0.77
In vitro transforming potential, intracellular signaling properties, and sensitivity to a kinase inhibitor (sorafenib) of RET proto-oncogene variants Glu511Lys, Ser649Leu, and Arg886Trp. Endocr Relat Cancer (2011) 0.77
Genetic alterations in thyroid tumors from patients irradiated in childhood for tinea capitis treatment. Eur J Endocrinol (2013) 0.77
Diagnostic and prognostic implications of the PAX8-PPARγ translocation in thyroid carcinomas-a TMA-based study of 226 cases. Histopathology (2013) 0.77
Thyroid and parathyroid tumours in patients submitted to X-ray scalp epilation during the tinea capitis eradication campaign in the North of Portugal (1950-1963). Virchows Arch (2014) 0.77
Overexpression of pyruvate dehydrogenase kinase supports dichloroacetate as a candidate for cutaneous melanoma therapy. Expert Opin Ther Targets (2015) 0.77
Increased lymphangiogenesis in Riedel thyroiditis (Immunoglobulin G4-related thyroid disease). Virchows Arch (2014) 0.76
Mucoepidermoid carcinoma of the thyroid: a tumour histotype characterised by P-cadherin neoexpression and marked abnormalities of E-cadherin/catenins complex. Virchows Arch (2002) 0.76
Alterations of the SDHD gene locus in midgut carcinoids. Genes Chromosomes Cancer (2003) 0.76